Study Stopped
personnel involved in clinical trial will not be available to conduct the research
Programmes de Marche Active et qualité de Vie Dans la Maladie de Parkinson
ACTI-PARK
Impact de Programmes de Marche Active Sur la Marche en Situation de Vie Quotidienne et la qualité de Vie Dans la Maladie de Parkinson
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
The aim of this randomized controlled pilot trial is to assess the impact of different gait rehabilitation programs on the level of physical activity and gait in daily life in patients with Parkinson's disease (PD). Two groups of 25 patients with PD will benefit from one of two gait training programs (treadmill vs. nordic walking), 3 times a week for 12 weeks. Activity level and number of steps will be remotely recorded over 7 days before, at the end, 3 and 6 months after the end of the program. Quality of life will be recorded at each time point. The impact of the gait programs on the patients' level of daily activity will be examined, comparing the changes brought about by the two programs, taking into account the modulating influence of age and cognitive function. Gait under conditions of daily life will be compared to gait parameters collected in the laboratory.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2023
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2022
CompletedFirst Posted
Study publicly available on registry
January 13, 2023
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedApril 6, 2023
April 1, 2023
2 years
September 1, 2022
April 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in daily energy expenditure
Evolution over time of the daily energy expenditure together with number of steps, as recorded using an actimeter worn at the belt.
recording 7 days in a row, at 3 months, 6 months and 9 months.
Secondary Outcomes (5)
Evolution of gait parameters
3 months, 6 months and 9 months.
Evolution of exercise functional capacity
3 months, 6 months and 9 months.
Evolution over time of the Parkinson's Disease Questionnaire-39 scale score.
3 months, 6 months and 9 months.
Evolution over time of the Parkinsons' Disease Fatigue Scale score.
3 months, 6 months and 9 months.
Adherence to the training program
3 months
Study Arms (2)
Treadmill walking
EXPERIMENTALThe training program will last 12 weeks and consist of treadmill walking. The duration of the walking bouts (and pauses), and the speed of the belt will be adjusted as needed following the patients' progress. Music will be added as suited to boost motivation and support regular cadence. All training sessions will be supervised.
Nordic walking
EXPERIMENTALThe training program will last 12 weeks and consist of Nordic walking, taught and supervised by an adapted physical activity teacher. The session will be carried out outside, weather permitting. When possible, training will gather 2 to 4 patients for group emulation. The duration of the walking bouts (and pauses) will be adjusted to follow the patients' progress.
Interventions
Supervised gait training program 3 times a week, 12 weeks
Eligibility Criteria
You may qualify if:
- Parkinson's disease, diagnosed for at least 2 years,
- Medical treatment (if any) unchanged in the past 4 weeks at least
- Hoehn \& Yahr score \< 3
- Montreal cognitive assessment (MOCA) score between 20 and 30
- Able to understand the aim and methods of the study and provide signed informed consent-
You may not qualify if:
- Atypical parkinsonian syndrome
- Cardiovascular pathology preventing moderate physical exercise
- Orthostatic hypotension
- Any condition (other than PD) interfering with gait
- pregnant or nursing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Grenoble Alpes
Grenoble, 38043, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moro Elena, MD PhD
Grenoble Alpes University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The researchers involved in data collection and in data analysis will be blinded with regard to the patients' group allocation. Randomization will be performed by an operator not otherwise involved in the study, under the RED-Cap application.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 1, 2022
First Posted
January 13, 2023
Study Start
February 1, 2023
Primary Completion
February 1, 2025
Study Completion (Estimated)
October 1, 2026
Last Updated
April 6, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share